Novo Nordisk A/S

Company overview

Novo Nordisk (or 'the company') is a leading global provider of diabetes products. The company also has a leadership position in hemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk primarily operates in Europe, North America and Japan. It is headquartered in Bagsvaerd, Denmark, and employed 38,436 people as of December 31, 2013.

The company recorded revenues of DKK83,572 million (approximately $14,884.2 million) during the financial year ended December 2013 (FY2013), an increase of 7.1% over FY2012. The operating profit of the company was DKK31,493 million (approximately $5,608.9 million) in FY2013, an increase of 6.9% over FY2012. The net profit was DKK25,184 million (approximately $4,485.3 million) in FY2013, an increase of 17.5% over FY2012.

Key facts

Novo Alle , 2880 Bagsvaerd , DNK

Fax : 45 4449 0555

http://www.novonordisk.com

New York Stock Exchange ticker: NVO

Copenhagen Stock Exchange ticker: NVO B

No. employees: 38436

Turnover: 83,572,000,000 (DKK)

Financial year end: December

Summary

  • Key facts
  • Overview
  • Business Description
  • History
  • Key Employees and Biographies
  • Location and Subsidiaries
  • Top Competitors
  • Major Products and Services

SWOT Profiles

This SWOT analysis company profile is the essential source for top level data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Scope of this research

  • Provides all the crucial company information required for business and competitor intelligence needs.
  • Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams.
  • Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Key reasons to purchase this research

  • Support sales activities by understanding your customers' businesses better
  • Qualify prospective partners and suppliers
  • Keep fully up to date on your competitors' business structure, strategy and prospects
  • Obtain the most up to date company information available

Company Profile

Published by
MarketLine
Published on
29 Oct 2014
Product code
793FBD68-AB0A-4E2F-90D1-3EAC58CB7A7B
Pages
Please wait...

$175

Multi-user License $438